The betulinic acid market size was valued at USD 2.5 billion in 2025 and is estimated to reach USD 4.8 billion by 2034, growing at a CAGR of 7.4% during the forecast period (2026-2034). Betulinic acid is getting traction for its immune-supporting and antioxidant benefits. Research highlights that it has as a promising candidate agent for cancer treatments.
Download Free Sample Report to Get Detailed Insights.
There is growing scientific evidence for the therapeutic potential of betulinic acid. It has shown selective cytotoxicity against tumor cells through apoptosis induction, sparing healthy tissues while targeting melanoma, glioblastoma, and pancreatic cancers. This has led to rising academic biotech research focused on understanding its mechanisms of action and developing formulations and derivatives for oncology applications. Scientists are conducting more research on how betulinic acid slows down the growth of tumor cells or triggers their death while causing less harm to normal healthy cells compared to many chemical cancer drugs. A study conducted by the School of Life Sciences and Health Engineering, Jiangnan University, found that betulinic acid significantly suppressed melanoma tumor growth.
The sudden surge of betulinic acids in cosmetics is due to their proven anti-aging, anti-inflammatory, and UV-protective properties. Consumers also prefer clean labels and herbal, chemical-free skincare products. Companies are now adding betulinic acid to creams, lotions, and serums. In nutraceuticals, it is getting traction for its immune-supporting, metabolic health, and antioxidant benefits. This expanding application is encouraging manufacturers to develop high-purity, cosmetic- and nutraceutical-grade betulinic acid while driving innovation in formulation compatibility and bioavailability.
Consumers worldwide are shifting toward preventive healthcare; thus, reliance on food supplements is growing. There has been a surge in the use of betulinic acid due to its antioxidant, anti-inflammatory, metabolic support, and immune-boosting properties. This makes it attractive for consumers seeking plant-based health products. Rising awareness of lifestyle-related disorders and the demand for clean botanical supplements are boosting the market. Betulinic acid combined with natural ingredients, such as green tea extract, curcumin, or resveratrol, enhances overall wellness benefits.
Supercritical COâ‚‚ extraction separates betulinic acid at high purity without using toxic organic solvents under controlled temperature and pressure conditions. Green solvents, such as ethanol, water-based mixtures, and natural deep eutectic solvents, support the efficient extraction and purification. The green solvent ensures that the final ingredient meets clean label expectations and regulatory safety limits.
Betulinic acid strongly relies on natural raw materials and complex extraction processes. Since the raw materials are sourced naturally, they face barriers such as geographic limitations, seasonal harvesting cycles, and forestry regulations. This, in turn, leads to scalability issues for manufacturers. High-purity extraction and purification require advanced technology, skilled labor, and multiple processing steps. Lack of technology or limited/unskilled human capital can restrict extraction capabilities, leading to supply shortages and price volatility.
Bioactive ingredients can be encapsulated in advanced delivery systems such as nanoparticles and liposomes, which protect it from degrading and improve solubility to reach target cells more efficiently. Targeted delivery of nanoparticles reduces major side effects, such as accumulation of formulation in organs and altered pharmacokinetics. These delivery methods enhance oral absorption so that more active compound enters the bloodstream and provides measurable health benefits. For example, Camurus AB, a biotech company, specializes in lipid nanocarriers and injectables for small molecules. Tiba Biotech offers biodegradable nanoparticle systems to enhance targeted delivery.
The natural betulinic acid segment accounted for the largest market share in 2025. Strong consumer preference for plant-derived compounds and sustainability aligns well with natural, clean-label, and sustainable ingredients. Natural betulinic acid is widely used in cosmetics, nutraceuticals, and pharmaceutical applications as a safer and more environmentally friendly alternative.
The synthetic betulinic acid segment is expected to grow at a CAGR of 10% during the forecast period. The growth is driven by drug development activities and rising pharmaceutical research. This acid is used in clinical research and advanced medical applications due to its purity, consistent quality, and scalability features.
Figure: Betulinic Acid Market Segments
TYPE
Natural Betulinic Acid
XX%
APPLICATION
Pharmaceutical Applications
REGION
North America
35%
The pharmaceutical applications segment holds the largest market share, accounting for 55% of total revenue in 2025. This segment is driven by extensive use of betulinic acid in drug development for anti-cancer, anti-inflammatory, and anti-viral properties. It can target diseased cells and comparatively cause less damage to healthy cells. Bioactive properties are highly valued by companies and researchers. Ongoing clinical research and studies further strengthen the role of betulinic acid in the pharmaceutical sector.
The cosmetics application segment is projected to grow at a CAGR of 7.5% during the forecast period. Natural active ingredients are incorporated into anti-aging, skin-smoothing, and repair-focused skincare products due to increasing inclination toward looking more youthful. With consumers becoming more selective, their awareness of clean-label ingredients is also increasing. Thus, the boost to the cosmetics industry is expected to propel market growth during the forecast period.
The betulinic acid market in North America had a market share of 35% in 2025. The growth is driven by strong pharmaceutical R&D capabilities and well-established cosmetics and nutraceutical industries. With increasing investments in cancer research focused on curbing tumor growth, triggering cancer cell death, and reducing metastasis, the region boasts of robust medical infrastructure. The American Cancer Society awarded 92 research grants in 2025, totaling USD 43.2 million. The region also has highly developed cosmetics and neurological industries, with a strong consumer preference for natural, plant-based ingredients.
The US is the fastest-growing country in North America, growing at a CAGR of 6.9% during the forecast period. US companies and research labs are actively focusing on advanced delivery systems such as nanoparticles and liposomes to overcome solubility and bioavailability limitations. Clear regulatory pathways for dietary supplements, cosmetic ingredients, and early-stage drug research make the US an attractive market for scaling and making betulinic acid-based products.
Europe held around 25% of the market share in 2025. Betulinic acid aligns well with European market preferences due to its plant-derived origin and multifunctional bioactivity. The region has a strict regulatory framework, such as REACH, which requires detailed chemical characterization, safety testing, and traceability. The legislation encourages the manufacturers to produce high-purity, well-characterized bioactive ingredients. European companies heavily focus on innovation, bioavailability, and product combinations.
Germany is expected to have considerable growth in the European region with a CAGR of 6.3%. German consumers are highly conscious and prefer plant-based and clinically supported ingredients. There are companies in Germany, such as Dermapharm AG, which emphasize innovation and R&D in natural and multifunctional formulants. Certification and labeling standards such as Cosmetic Organic and Natural Standard (COSMOS) help verify that the products are truly natural or organic and build consumer trust.
Asia Pacific accounted for 20% of the market share in 2025, owing to large-scale extraction and manufacturing facilities to produce high-purity bioactive compounds. The personal care industry in the Asia Pacific is currently growing rapidly, as consumers prefer plant-based, multifunctional, and safe ingredients. Developing countries in this region are also exhibiting initiatives to integrate modern products in treatments. For instance, the Ayush Promotion Policy by the Government of India aims to integrate traditional medicines with modern wellness products.
China is expected to grow at a CAGR of 7.2% during the forecast period. China combines traditional medicines with modern nutraceutical and pharmaceutical R&D. It is also investing in pharmaceutical and bioactive research. For instance, a December 2025 study revealed co-delivery systems with betulinic acid for cancer immunotherapy. The country also has ample raw materials to scale up production due to the presence of birch-producing areas, such as Northeast China. These factors make China a leading country in the Asia Pacific market.
Latin America held 15% of the global market share in 2025. The region has rich biodiversity and plant-based raw materials, which makes it suitable for extracting bioactive compounds. The availability of raw materials enables both local production and export, lowering costs and market growth. Consumers have also started showing interest in herbal supplements, which encourages companies to incorporate bioactive compounds.
Brazil is experiencing considerable growth in the Latin American region, with a CAGR of 6.8% during the forecast period. Brazil provides many sources of plant compounds due to an abundance of natural resources. The Brazilian Health Regulatory Agency plays a vital role in the regulatory framework for herbal supplements and cosmetic products. The country has a growing focus on bioactive therapeutic research, an established natural product industry, and a growing trend toward functional health ingredients.
The Middle East & Africa region accounted for 5% of market share in 2025. The region heavily relies on imports of premium nutraceuticals and cosmetic products from Europe, North America, and Asia Pacific. The imports often feature bioactive ingredients, helping to introduce and expand their market presence.
South Africa is the fastest-growing country in the Middle East & Africa region, with a CAGR of 6.5% during the forecast period. South Africa has a diverse flora, which makes it suitable for extracting natural bioactive. In 2025, South Africa launched a National Action Plan (NAP) to prevent substandard and fake medical products by monitoring supply chain and traceability across health sectors.
US Food and Drug Administration (FDA)
US
European Food Safety Authority
Europe
Saudi Food and Drug Authority
Saudi Arabia
ANVISA
Brazil
Food Safety and Standards Authority of India (FSSAI)
India
The betulinic acid market is moderately fragmented with competition among multinational cosmetic and pharmaceutical corporations, regional extraction manufacturers, nutraceutical firms, and private firm suppliers. The regional manufacturers compete on cost and locally sourced formulations. The intensity of competition in this market is based on a combination of factors such as product innovation, bioactive quality, and regulatory compliance. Emerging trends in this market include rising investment in anti-inflammatory and anti-tumor properties and the incorporation of betulinic acid in nutraceuticals and cosmeceuticals.
Customize This Report to Match Your Strategic Objectives
Author's Details
Senior Research Analyst
Harshit Ranaware is a Senior Research Analyst with over 5+ years of expertise in Bulk Chemicals, Advanced Materials, Specialty Chemicals, and Mining Minerals & Metals. His research blends technical depth with market intelligence, delivering data-driven insights to help businesses navigate complex industrial landscapes. Harshit's analytical approach and commitment to accuracy make him a trusted source for understanding evolving market dynamics in the global chemicals and mining sectors.
We are featured on:
sales@straitsresearch.com